Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,291 active trials259 approved drugs3,814 evidence items
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,377 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03131934 | Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant(ITREC) | completed | Early Phase 1 | 4 | University College, LondonOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT03408314 | The PediQUEST Response Intervention Study | completed | N/A | 194 | Joanne Wolfe, MD, MPHOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT03416153 | Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer | completed | Phase 2 | 91 | University of Michigan Rogel Cancer CenterOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT03573024 | Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia | completed | Phase 2 | 36 | University of Colorado, DenverOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT04145349 | CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor | completed | Phase 1 / Phase 2 | 30 | Eli Lilly and CompanyINDUSTRY | 7 | Aug 7, 2026 | clinicaltrials |
| NCT05156931 | Exploration of Patient Self-medication Practices During and After Cancer in France(CASEME) | completed | — | 681 | University Hospital, Clermont-FerrandOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT05794607 | The Effectiveness of Tele-Pulmonary Rehabilitation After Lung Resection | completed | N/A | 36 | Halime Sinem BarutçuOTHER_GOV | 1 | Aug 7, 2026 | clinicaltrials |
| NCT06498674 | AI-Assisted Ultrasound Review Before Thyroid Surgery | completed | N/A | 515 | Fujian Medical UniversityOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT06674499 | Development and Evaluation of a Self-Management Model for Cancer Rehabilitation | completed | N/A | 144 | Xingchen PengOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT07073807 | Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy(SMART pilot) | completed | N/A | 35 | University of California, IrvineOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT07752667 | The Effect of a Music-Assisted Mandala Intervention on Psychological Well-being and Quality of Life in Cancer Patients Undergoing Chemotherapy | completed | N/A | 40 | Istanbul Medeniyet UniversityOTHER | 1 | Aug 7, 2026 | clinicaltrials |
| NCT01547741 | Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer | completed | Phase 3 | 4,242 | NSABP Foundation IncNETWORK | 2 | Aug 6, 2026 | clinicaltrials |
| NCT02489084 | Predictive Models for Radiation-induced Side Effects in Head and Neck Cancer Based on Single Nucleotide Polymorphisms (SNP)(HANS) | completed | — | 2,000 | University Medical Center GroningenOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT02561234 | A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors | completed | Phase 1 | 76 | Immedica Pharma ABINDUSTRY | 1 | Aug 6, 2026 | clinicaltrials |
| NCT02970448 | Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade Gliomas | completed | Early Phase 1 | 13 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT03776253 | Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer | completed | N/A | 39 | City of Hope Medical CenterOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT03924050 | Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI | completed | Phase 3 | 440 | Shanghai Junshi Bioscience Co., Ltd.OTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT04104139 | TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer | completed | Phase 1 | 19 | OHSU Knight Cancer InstituteOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT04386967 | OH2 Injection in Solid Tumors | completed | Phase 1 / Phase 2 | 44 | Binhui Biopharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 6, 2026 | clinicaltrials |
| NCT04730869 | Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma | completed | N/A | 18 | Waikato HospitalOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT04862325 | SOPHIE Trial: Surgery in Ovarian Cancer With PreHabilitation In ERAS(SOPHIE) | completed | N/A | 158 | Hospital Clinic of BarcelonaOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT05650710 | Intraoperative Ansa Cervicalis Nerve (ACN) Stimulation(ACS) | completed | N/A | 51 | Vanderbilt University Medical CenterOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT05785845 | Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer | completed | N/A | 17 | Washington University School of MedicineOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT06237582 | Inferior Epigastric Lymp Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Ovarian Peritoneal Metastases(OvEpiLyPath) | completed | N/A | 20 | Jules Bordet InstituteOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT07745946 | The Effect of Virtual Reality Glasses and Breathing Exercise on Anxiety | completed | N/A | 107 | Ankara Medipol UniversityOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT07749443 | Construction and Empirical Study of Indirect Intervention Model for Protective Medical Lung Cancer Patients Based on Family System Theory(FST) | completed | N/A | 160 | Anhui Medical UniversityOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT00911560 | Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma | completed | Phase 1 / Phase 2 | 374 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT01394939 | Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma | completed | Phase 1 / Phase 2 | 52 | Jennerex BiotherapeuticsINDUSTRY | 3 | Aug 5, 2026 | clinicaltrials |
| NCT01494155 | Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer | completed | Phase 2 | 50 | Massachusetts General HospitalOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT02296684 | Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma | completed | Phase 2 | 67 | Washington University School of MedicineOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT02970513 | Psychological Evaluation According Colonic Colonization by Escherichia Coli of Patients After Colorectal Surgery(MicrobioPSY) | completed | N/A | 12 | University Hospital, Clermont-FerrandOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT03026062 | Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | completed | Phase 2 | 100 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT04827862 | RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab + Low Dose Radiotherapy | completed | Phase 2 | 6 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT06006403 | Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm | completed | Phase 1 / Phase 2 | 5 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Aug 5, 2026 | clinicaltrials |
| NCT06249854 | Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 26 | Korea Institute of Oriental MedicineOTHER_GOV | 1 | Aug 5, 2026 | clinicaltrials |
| NCT06375707 | First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer | completed | Phase 2 | 74 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT06681935 | Defining Mechanisms of Surgical Site Infection After Oral Cancer Surgery | completed | — | 40 | Medical College of WisconsinOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT06714292 | Fluorescent Approach for Refined Endoscopic Marking With Clip Localization and Identification Procedure(FLARECLIP) | completed | Phase 2 | 110 | Seoul National University HospitalOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT07261267 | Music Therapy's Effect on Cancer Patients Undergoing Radiotherapy | completed | N/A | 72 | Kocaeli UniversityOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT07746310 | Dietary Nitrate and Nitrite Intake and Phosphate Biomarkers and Risk of Chronic Diseases | completed | — | 86,000 | Karolinska InstitutetOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT02101788 | Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer | completed | Phase 2 / Phase 3 | 260 | National Cancer Institute (NCI)NIH | 2 | Aug 4, 2026 | clinicaltrials |
| NCT02211768 | Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 | completed | Phase 1 | 10 | National Cancer Institute (NCI)NIH | 1 | Aug 4, 2026 | clinicaltrials |
| NCT03143270 | A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer | completed | Early Phase 1 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 4, 2026 | clinicaltrials |
| NCT04640259 | Epidemiology of Young Lung Cancer - Survey(EoYLC) | completed | — | 187 | Addario Lung Cancer Medical InstituteOTHER | 1 | Aug 4, 2026 | clinicaltrials |
| NCT04825288 | XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer(1-BETTER) | completed | Phase 1 / Phase 2 | 76 | XBiotech, Inc.INDUSTRY | 1 | Aug 4, 2026 | clinicaltrials |
| NCT05080166 | UPLYFT For Lymphoma Survivors | completed | N/A | 74 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 4, 2026 | clinicaltrials |
| NCT06448793 | Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments | completed | — | 650 | Bristol-Myers SquibbINDUSTRY | 1 | Aug 4, 2026 | clinicaltrials |
| NCT06539195 | DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9) | completed | Phase 2 | 59 | Dizal PharmaceuticalsINDUSTRY | 1 | Aug 4, 2026 | clinicaltrials |
| NCT06595498 | Next Generation Sequencing Method for the Detection of EGFR Gene Mutations in the Plasma of Patients With Lung Cancer | completed | N/A | 130 | Istituto Oncologico Veneto IRCCSOTHER | 1 | Aug 4, 2026 | clinicaltrials |
| NCT06687538 | Effect of Education to be Provided to Patients to Undergo TURP With Mobile Application on Patient Outcomes | completed | N/A | 68 | Tarsus UniversityOTHER | 1 | Aug 4, 2026 | clinicaltrials |
Data updated 24 days agoSource updated Aug 7, 2026source: clinicaltrials